Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

11C-glyburide PET imaging unveils the negligible brain penetration of glyburide in humans.

Marie S, Comtat C, Caillé F, Becquemont L, Bottlaender M, Tournier N.

Neurology. 2019 Apr 23;92(17):813-814. doi: 10.1212/WNL.0000000000007378. No abstract available.

PMID:
31010910
2.

Cardiovascular Disease in Type 2 Diabetes: A Review of Sex-Related Differences in Predisposition and Prevention.

Al-Salameh A, Chanson P, Bucher S, Ringa V, Becquemont L.

Mayo Clin Proc. 2019 Feb;94(2):287-308. doi: 10.1016/j.mayocp.2018.08.007. Review.

PMID:
30711127
3.

Methemoglobinemia as a biomarker of dapsone-induced mania severity.

Colle R, Ait Tayeb AEK, Mesdom P, de Menthon M, Becquemont L, Verstuyft C, David DJ, Lambotte O, Corruble E.

J Affect Disord. 2018 Dec 25. pii: S0165-0327(18)32431-5. doi: 10.1016/j.jad.2018.12.123. [Epub ahead of print]

PMID:
30598189
4.

HOMA-IR increase after antidepressant treatment in depressed patients with the Met allele of the Val66Met BDNF genetic polymorphism.

Martin S, Colle R, El Asmar K, Rigal A, Vievard A, Feve B, Becquemont L, Verstuyft C, Corruble E.

Psychol Med. 2018 Dec 11:1-6. doi: 10.1017/S0033291718003240. [Epub ahead of print]

PMID:
30526722
5.

Early weight gain predicts later metabolic syndrome in depressed patients treated with antidepressants: Findings from the METADAP cohort.

El Asmar K, Fève B, Colle R, Trabado S, Verstuyft C, Gressier F, Vievard A, Haffen E, Polosan M, Ferreri F, Falissard B, Chanson P, Becquemont L, Corruble E.

J Psychiatr Res. 2018 Dec;107:120-127. doi: 10.1016/j.jpsychires.2018.10.021. Epub 2018 Oct 28.

PMID:
30390577
6.

The TRKB rs2289656 genetic polymorphism is associated with acute suicide attempts in depressed patients: A transversal case control study.

Deflesselle E, Colle R, Rigal L, David DJ, Vievard A, Martin S, Becquemont L, Verstuyft C, Corruble E.

PLoS One. 2018 Oct 11;13(10):e0205648. doi: 10.1371/journal.pone.0205648. eCollection 2018.

7.

Differential pharmacokinetic interaction of cyclosporine and tacrolimus with colchicine in renal allograft recipients.

Beaudreuil S, Schermann JM, Verstuyft C, Barrail-Tran A, Smirnova M, Durrbach A, Becquemont L.

Clin Transplant. 2018 Nov;32(11):e13405. doi: 10.1111/ctr.13405. Epub 2018 Oct 8. No abstract available.

PMID:
30298530
8.

Sex Differences in the Occurrence of Major Clinical Events in Elderly People with Type 2 Diabetes Mellitus Followed up in the General Practice.

Al-Salameh A, Bucher S, Bauduceau B, Benattar-Zibi L, Berrut G, Bertin P, Corruble E, Danchin N, Derumeaux G, Doucet J, Falissard B, Forette F, Hanon O, Ourabah R, Pasquier F, Pinget M, Becquemont L, Ringa V.

Exp Clin Endocrinol Diabetes. 2018 Aug 22. doi: 10.1055/a-0662-5923. [Epub ahead of print]

PMID:
30134475
9.

Early weight gain predicts later weight gain in depressed patients treated with antidepressants: Findings from the METADAP cohort.

Asmar KE, Fève B, Colle R, Gressier F, Vievard A, Trabado S, Verstuyft C, Haffen E, Polosan M, Ferreri F, Falissard B, Chanson P, Becquemont L, Corruble E.

J Affect Disord. 2018 Dec 1;241:22-28. doi: 10.1016/j.jad.2018.07.059. Epub 2018 Jul 26.

PMID:
30092445
10.

Glycogen synthase kinase-3β genetic polymorphisms and insomnia in depressed patients: A prospective study.

Costemale-Lacoste JF, Colle R, Martin S, Asmar KE, Loeb E, Feve B, Verstuyft C, Trabado S, Ferreri F, Haffen E, Polosan M, Becquemont L, Corruble E.

J Affect Disord. 2018 Nov;240:230-236. doi: 10.1016/j.jad.2018.07.062. Epub 2018 Jul 24.

PMID:
30081294
11.

Framingham coronary score in individuals with symptoms or diagnoses of mental disorders: A review and meta-analysis.

Rigal A, Colle R, El Asmar K, Elie-Lefebvre C, Falissard B, Becquemont L, Verstuyft C, Corruble E.

Psychiatry Res. 2018 May;263:41-47. doi: 10.1016/j.psychres.2018.02.035. Epub 2018 Feb 19. Review.

PMID:
29494881
12.

[Dihydropyrimidine déhydrogenase (DPD) deficiency screening and securing of fluoropyrimidine-based chemotherapies: Update and recommendations of the French GPCO-Unicancer and RNPGx networks].

Loriot MA, Ciccolini J, Thomas F, Barin-Le-Guellec C, Royer B, Milano G, Picard N, Becquemont L, Verstuyft C, Narjoz C, Schmitt A, Bobin-Dubigeon C, Harle A, Paci A, Poinsignon V, Quaranta S, Evrard A, Hennart B, Broly F, Fonrose X, Lafay-Chebassier C, Wozny AS, Masskouri F, Boyer JC, Etienne-Grimaldi MC.

Bull Cancer. 2018 Apr;105(4):397-407. doi: 10.1016/j.bulcan.2018.02.001. Epub 2018 Feb 24. Review. French.

13.

Looking younger, dying later: General practitioners' intuitive clinical impression predicts mortality.

Bucher S, Al-Salameh A, Panjo H, Becquemont L, Ringa V; S.AGES investigators.

Prev Med. 2018 Jun;111:28-34. doi: 10.1016/j.ypmed.2018.02.022. Epub 2018 Feb 21. No abstract available.

PMID:
29474849
14.

A Somewhat Bizarre Case of Graves Disease Due to Vitamin Treatment.

Al-Salameh A, Becquemont L, Brailly-Tabard S, Aubourg P, Chanson P.

J Endocr Soc. 2017 Mar 23;1(5):431-435. doi: 10.1210/js.2017-00054. eCollection 2017 May 1.

15.

Gender-Related Differences in the Control of Cardiovascular Risk Factors in Primary Care for Elderly Patients With Type 2 Diabetes: A Cohort Study.

Al-Salameh A, Bucher S, Bauduceau B, Benattar-Zibi L, Berrut G, Bertin P, Corruble E, Danchin N, Derumeaux G, Doucet J, Falissard B, Forette F, Hanon O, Ourabah R, Pasquier F, Pinget M, Ringa V, Becquemont L.

Can J Diabetes. 2018 Aug;42(4):365-371.e2. doi: 10.1016/j.jcjd.2017.08.248. Epub 2017 Oct 13.

PMID:
29037572
16.

The association of β-arrestin2 polymorphisms with response to antidepressant treatment in depressed patients.

Petit AC, El Asmar K, David DJ, Gardier AM, Becquemont L, Fève B, Verstuyft C, Corruble E.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:74-79. doi: 10.1016/j.pnpbp.2017.10.006. Epub 2017 Oct 12.

PMID:
29031912
17.

HLA-associated drug hypersensitivity and the prediction of adverse drug reactions.

Negrini S, Becquemont L.

Pharmacogenomics. 2017 Oct;18(15):1441-1457. doi: 10.2217/pgs-2017-0090. Epub 2017 Oct 11. Review.

PMID:
29017379
18.

Plasma BDNF Level in Major Depression: Biomarker of the Val66Met BDNF Polymorphism and of the Clinical Course in Met Carrier Patients.

Colle R, Trabado S, David DJ, Brailly-Tabard S, Hardy P, Falissard B, Fève B, Becquemont L, Verstuyft C, Corruble E.

Neuropsychobiology. 2017;75(1):39-45. doi: 10.1159/000478862. Epub 2017 Aug 23.

PMID:
28848102
19.

The Catechol-O-methyltransferase Val(108/158)Met Genetic Polymorphism cannot be Recommended as a Biomarker for the Prediction of Venlafaxine Efficacy in Patients Treated in Psychiatric Settings.

Taranu A, Asmar KE, Colle R, Ferreri F, Polosan M, David D, Becquemont L, Corruble E, Verstuyft C.

Basic Clin Pharmacol Toxicol. 2017 Nov;121(5):435-441. doi: 10.1111/bcpt.12827. Epub 2017 Aug 6.

20.

Should a routine genotyping of CYP2D6 and CYP2C19 genetic polymorphisms be recommended to predict venlafaxine efficacy in depressed patients treated in psychiatric settings?

Taranu A, Colle R, Gressier F, El Asmar K, Becquemont L, Corruble E, Verstuyft C.

Pharmacogenomics. 2017 May;18(7):639-650. doi: 10.2217/pgs-2017-0003. Epub 2017 May 8.

PMID:
28480819
21.

Severe insomnia is associated with hypertriglyceridemia in women with major depression treated in psychiatry settings.

Costemale-Lacoste JF, Trabado S, Verstuyft C, El Asmar K, Butlen-Ducuing F, Colle R, Ferreri F, Polosan M, Haffen E, Balkau B, Falissard B, Feve B, Becquemont L, Corruble E.

J Affect Disord. 2017 Aug 1;217:159-162. doi: 10.1016/j.jad.2017.04.011. Epub 2017 Apr 9.

PMID:
28411504
22.

The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age.

Trabado S, Al-Salameh A, Croixmarie V, Masson P, Corruble E, Fève B, Colle R, Ripoll L, Walther B, Boursier-Neyret C, Werner E, Becquemont L, Chanson P.

PLoS One. 2017 Mar 9;12(3):e0173615. doi: 10.1371/journal.pone.0173615. eCollection 2017.

23.

No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients.

Deflesselle E, Verstuyft C, Petit AC, Hardy P, David DJ, Falissard B, Fève B, Rigal L, Becquemont L, Corruble E, Colle R.

Pharmacogenomics. 2017 Mar;18(4):349-357. doi: 10.2217/pgs-2016-0165. Epub 2017 Feb 17.

PMID:
28244805
24.

Type 1 Gaucher disease (CYP2D6-eliglustat).

Becquemont L.

Therapie. 2017 Apr;72(2):323-326. doi: 10.1016/j.therap.2016.09.019. Epub 2017 Jan 30.

PMID:
28242126
25.

Editorial.

Becquemont L, Picard N, Verstuyft C.

Therapie. 2017 Apr;72(2):173-174. doi: 10.1016/j.therap.2017.01.004. Epub 2017 Jan 30. No abstract available.

PMID:
28238399
26.

Maladie de Gaucher de type 1 (CYP2D6-éliglustat).

Becquemont L.

Therapie. 2017 Apr;72(2):319-322. doi: 10.1016/j.therap.2016.09.013. Epub 2017 Jan 3. French. No abstract available.

PMID:
28189332
27.

Pharmacogenetics of hypersensitivity drug reactions.

Negrini S, Becquemont L.

Therapie. 2017 Apr;72(2):231-243. doi: 10.1016/j.therap.2016.12.009. Epub 2017 Jan 3. Review.

PMID:
28162244
28.

Éditorial.

Becquemont L, Picard N, Verstuyft C.

Therapie. 2017 Apr;72(2):171-172. doi: 10.1016/j.therap.2016.12.008. Epub 2017 Jan 3. French. No abstract available.

PMID:
28117096
29.

Tobacco use is associated with increased plasma BDNF levels in depressed patients.

Colle R, Trabado S, Rotenberg S, Brailly-Tabard S, Benyamina A, Aubin HJ, Hardy P, Falissard B, Becquemont L, Verstuyft C, Fève B, Corruble E.

Psychiatry Res. 2016 Dec 30;246:370-372. doi: 10.1016/j.psychres.2016.10.012. Epub 2016 Oct 12.

PMID:
27788454
30.

Relationship between achieved personalized glycaemic targets and monitoring of clinical events in elderly diabetic patients.

Bucher S, Panjo H, Al-Salameh A, Bauduceau B, Benattar-Zibi L, Bertin P, Berrut G, Corruble E, Danchin N, Derumeaux G, Doucet J, Falissard B, Forette F, Hanon O, Ourabah R, Pasquier F, Piedvache C, Pinget M, Becquemont L, Ringa V; representing the S. AGES investigators.

Diabetes Metab. 2017 Feb;43(1):59-68. doi: 10.1016/j.diabet.2016.05.008. Epub 2016 Jun 15.

PMID:
27316980
31.

The contribution of pharmacogenetics to pharmacovigilance.

Bondon-Guitton E, Despas F, Becquemont L.

Therapie. 2016 Apr;71(2):223-8. doi: 10.1016/j.therap.2016.02.005. Epub 2016 Mar 3. English, French.

PMID:
27080842
32.

Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with Cyclophosphamide.

Audemard-Verger A, Martin Silva N, Verstuyft C, Costedoat-Chalumeau N, Hummel A, Le Guern V, Sacré K, Meyer O, Daugas E, Goujard C, Sultan A, Lobbedez T, Galicier L, Pourrat J, Le Hello C, Godin M, Morello R, Lambert M, Hachulla E, Vanhille P, Queffeulou G, Potier J, Dion JJ, Bataille P, Chauveau D, Moulis G, Farge-Bancel D, Duhaut P, Saint-Marcoux B, Deroux A, Manuzak J, Francès C, Aumaitre O, Bezanahary H, Becquemont L, Bienvenu B.

PLoS One. 2016 Mar 22;11(3):e0151696. doi: 10.1371/journal.pone.0151696. eCollection 2016.

33.

Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.

Qesseveur G, Petit AC, Nguyen HT, Dahan L, Colle R, Rotenberg S, Seif I, Robert P, David D, Guilloux JP, Gardier AM, Verstuyft C, Becquemont L, Corruble E, Guiard BP.

Neuropharmacology. 2016 Jun;105:142-153. doi: 10.1016/j.neuropharm.2015.12.022. Epub 2016 Jan 4.

PMID:
26764241
34.

Cardiovascular Drugs and Metformin Drug Dosage According to Renal Function in Non-Institutionalized Elderly Patients.

Becquemont L, Bauduceau B, Benattar-Zibi L, Al-Salameh A, Berrut G, Bertin P, Bucher S, Corruble E, Danchin N, Derumeaux G, Doucet J, Falissard B, Forette F, Hanon O, Pasquier F, Pinget M, Ourabah R, Piedvache C.

Basic Clin Pharmacol Toxicol. 2016 Jun;118(6):468-73. doi: 10.1111/bcpt.12526. Epub 2015 Dec 28.

35.

Treating major depressive episodes with antidepressants can induce or worsen metabolic syndrome: results of the METADAP cohort.

Corruble E, El Asmar K, Trabado S, Verstuyft C, Falissard B, Colle R, Petit AC, Gressier F, Brailly-Tabard S, Ferreri F, Lépine JP, Haffen E, Polosan M, Bourrier C, Perlemuter G, Chanson P, Fève B, Becquemont L.

World Psychiatry. 2015 Oct;14(3):366-7. doi: 10.1002/wps.20260. No abstract available.

36.

Tobacco Consumption Concerns With the Use of CYP1A2 Metabolized Antidepressants.

Gressier F, Rotenberg S, Ait Tayeb AE, Colle R, Hardy P, Becquemont L, Verstuyft C, Corruble E.

Am J Psychiatry. 2015 Sep 1;172(9):909-10. doi: 10.1176/appi.ajp.2015.15010033. No abstract available.

PMID:
26324305
37.

Healthcare costs associated with elderly chronic pain patients in primary care.

Lazkani A, Delespierre T, Bauduceau B, Pasquier F, Bertin P, Berrut G, Corruble E, Doucet J, Falissard B, Forette F, Hanon O, Benattar-Zibi L, Piedvache C, Becquemont L.

Eur J Clin Pharmacol. 2015 Aug;71(8):939-47. doi: 10.1007/s00228-015-1871-6. Epub 2015 May 26.

PMID:
26004570
38.

Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients.

Colle R, Gressier F, Verstuyft C, Deflesselle E, Lépine JP, Ferreri F, Hardy P, Guilloux JP, Petit AC, Fève B, Falissard B, Becquemont L, Corruble E.

J Affect Disord. 2015 Apr 1;175:233-40. doi: 10.1016/j.jad.2015.01.013. Epub 2015 Jan 21.

PMID:
25658497
39.

Therapeutic management in ambulatory elderly patients with atrial fibrillation: the S.AGES cohort.

Hanon O, Vidal JS, Pisica-Donose G, Benattar-Zibi L, Bertin P, Berrut G, Corruble E, Derumeaux G, Falissard B, Forette F, Pasquier F, Pinget M, Ourabah R, Becquemont L, Danchin N; S.AGES Investigators.

J Nutr Health Aging. 2015 Feb;19(2):219-27. doi: 10.1007/s12603-015-0444-9.

PMID:
25651449
40.

Predicting falls in elderly patients with chronic pain and other chronic conditions.

Lazkani A, Delespierre T, Bauduceau B, Benattar-Zibi L, Bertin P, Berrut G, Corruble E, Danchin N, Derumeaux G, Doucet J, Falissard B, Forette F, Hanon O, Pasquier F, Pinget M, Ourabah R, Piedvache C, Becquemont L.

Aging Clin Exp Res. 2015 Oct;27(5):653-61. doi: 10.1007/s40520-015-0319-2. Epub 2015 Jan 31.

PMID:
25637513
41.

Association between Cardiovascular Drugs and Chronic Kidney Disease in Non-Institutionalized Elderly Patients.

Becquemont L, Bauduceau B, Benattar-Zibi L, Berrut G, Bertin P, Bucher S, Corruble E, Danchin N, al-Salameh A, Derumeaux G, Doucet J, Falissard B, Forette F, Hanon O, Pasquier F, Pinget M, Ourabah R, Piedvache C.

Basic Clin Pharmacol Toxicol. 2015 Aug;117(2):137-43. doi: 10.1111/bcpt.12376. Epub 2015 Feb 3.

42.

Impact of pregnancy on psychotropic medication prescription: a French cohort study.

Apter G, Devouche E, Becquemont L.

Therapie. 2015 May-Jun;70(3):251-7. doi: 10.2515/therapie/2014212. Epub 2014 Dec 24.

PMID:
25534518
43.

Do male and female general practitioners differently prescribe chronic pain drugs to older patients?

Lazkani A, Delespierre T, Benattar-Zibi L, Bertin P, Corruble E, Derumeaux G, Falissard B, Forette F, Hanon O, Piedvache C, Becquemont L.

Pain Med. 2015 Apr;16(4):696-705. doi: 10.1111/pme.12659. Epub 2014 Dec 17.

PMID:
25521663
44.

Safety and pharmacokinetics of the CIME combination of drugs and their metabolites after a single oral dosing in healthy volunteers.

Lenuzza N, Duval X, Nicolas G, Thévenot E, Job S, Videau O, Narjoz C, Loriot MA, Beaune P, Becquemont L, Mentré F, Funck-Brentano C, Alavoine L, Arnaud P, Delaforge M, Bénech H.

Eur J Drug Metab Pharmacokinet. 2016 Apr;41(2):125-38. doi: 10.1007/s13318-014-0239-0. Epub 2014 Dec 3.

PMID:
25465228
45.

Menopausal status could modulate the association between 5-HTTLPR and antidepressant efficacy in depressed women: a pilot study.

Gressier F, Verstuyft C, Hardy P, Becquemont L, Corruble E.

Arch Womens Ment Health. 2014 Dec;17(6):569-73. doi: 10.1007/s00737-014-0464-1. Epub 2014 Sep 26.

PMID:
25257397
46.

Proton pump inhibitors inhibit methotrexate transport by renal basolateral organic anion transporter hOAT3.

Chioukh R, Noel-Hudson MS, Ribes S, Fournier N, Becquemont L, Verstuyft C.

Drug Metab Dispos. 2014 Dec;42(12):2041-8. doi: 10.1124/dmd.114.058529. Epub 2014 Sep 19.

PMID:
25239859
47.

Primary care management of non-institutionalized elderly diabetic patients: The S.AGES cohort - Baseline data.

Bucher S, Bauduceau B, Benattar-Zibi L, Bertin P, Berrut G, Corruble E, Danchin N, Delespierre T, Derumeaux G, Doucet J, Falissard B, Forette F, Hanon O, Ourabah R, Pasquier F, Piedvache C, Pinget M, Ringa V, Becquemont L; S.AGES Investigators.

Prim Care Diabetes. 2015 Aug;9(4):267-74. doi: 10.1016/j.pcd.2014.07.004. Epub 2014 Jul 31.

PMID:
25086913
48.

Serotonin toxicity in a CYP2D6 poor metabolizer, initially diagnosed as a drug-resistant major depression.

Gressier F, Ellul P, Dutech C, Ait Tayeb Ael K, Monfort J, Corruble E, Becquemont L, Hardy P, Verstuyft C.

Am J Psychiatry. 2014 Aug;171(8):890. doi: 10.1176/appi.ajp.2014.13101377. No abstract available.

PMID:
25082493
49.

Consequences of dextropropoxyphene market withdrawal in elderly patients with chronic pain.

Becquemont L, Delespierre T, Bauduceau B, Benattar-Zibi L, Berrut G, Corruble E, Danchin N, Derumeaux G, Doucet J, Falissard B, Forette F, Hanon O, Pasquier F, Pinget M, Ourabah R, Bucher S, Lazkani A, Piedvache C, Bertin P.

Eur J Clin Pharmacol. 2014 Oct;70(10):1237-42. doi: 10.1007/s00228-014-1722-x. Epub 2014 Jul 29.

PMID:
25066451
50.

Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors.

Gressier F, Verstuyft C, Hardy P, Becquemont L, Corruble E.

J Neural Transm (Vienna). 2015 Jan;122(1):35-42. doi: 10.1007/s00702-014-1273-4. Epub 2014 Jul 22.

PMID:
25047911

Supplemental Content

Loading ...
Support Center